The evaluations were carried out at the beginning of treatment with MM (except the Global Assessment Scale - GAS), and then 1 month and 3 months after that, with the GAS used for all 3 subgroups, the Barthel Index for the subgroup with multiple cerebral infarcts, and the MRC scale for deltoid muscle in the subgroup with polymyositis.